Replies to post #225762 on Biotech Values

[DewDiligence]

RNAi-based compounds are simpy "too effective" in bringing down HBV RNA/DNA, i.e. too strong competition.

I’m not convinced that the RNAi approaches will be able to eradicate HBV (#msg-148259590).